Search results for "ship"

showing 10 items of 6731 documents

Dose-dependent absorption and elimination of cefadroxil in man.

1991

The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30 mg.kg-1. As the dose of cefadroxil increased from 5 to 15 and 30 mg.kg-1, the peak plasma concentrations, normalized to 5 mg.kg-1, decreased significantly from 15.1 to 10.7 and 7.6 mg.l-1, while the corresponding normalized areas under the plasma concentration-time curves from 0 to 2 h decreased significantly from 1258 to 946 and 801 min.mg.l-1. When the same subjects were given 5 mg.kg-1 of cefadroxil together with 45 mg.kg-1 of cephalexin, the absorption of cefadroxil was slowed to a similar or greater extent than with the high dose o…

AdultMaleAdolescentmedicine.drug_classMetabolic Clearance RateAntibioticsAbsorption (skin)PharmacologyKidneyAbsorptionPharmacokineticsOral administrationReference ValuesmedicineHumansPharmacology (medical)Drug InteractionsPharmacologyCephalexinDose-Response Relationship DrugChemistryCefadroxilKidney metabolismGeneral MedicineDrug interactionDose–response relationshipCefadroxilmedicine.drugEuropean journal of clinical pharmacology
researchProduct

Prediction of the hemoglobin level in hemodialysis patients using machine learning techniques

2013

HighlightsDifferent prediction algorithms were used to predict Hb levels in CRF patients.Prediction errors in the validation cohorts of patients were around 0.6g/dl.Difficulty to obtain lower errors due to the measuring machine precision (0.2g/dl).Relevance analysis of features have been applied for each predictor. Patients who suffer from chronic renal failure (CRF) tend to suffer from an associated anemia as well. Therefore, it is essential to know the hemoglobin (Hb) levels in these patients. The aim of this paper is to predict the hemoglobin (Hb) value using a database of European hemodialysis patients provided by Fresenius Medical Care (FMC) for improving the treatment of this kind of …

AdultMaleAdolescentmedicine.medical_treatmentHealth InformaticsMachine learningcomputer.software_genreDisease clusterSensitivity and SpecificityHemoglobinsYoung AdultArtificial IntelligenceRenal DialysismedicineHumansComputer SimulationCluster analysisErythropoietinAgedAged 80 and overDose-Response Relationship DrugArtificial neural networkbusiness.industryModels CardiovascularLinear modelReproducibility of ResultsAnemiaMiddle AgedRegressionDrug Therapy Computer-AssistedComputer Science ApplicationsSupport vector machineTreatment OutcomeAdaptive resonance theoryFemaleHemodialysisArtificial intelligenceDrug MonitoringbusinesscomputerAlgorithmsBiomarkersSoftwareComputer Methods and Programs in Biomedicine
researchProduct

Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin

1997

Purpose: The goal of this study was to determine the effects of vasopressin and the selective V 2 -receptor agonist desmopressin on human saphenous veins, with special emphasis on endothelium-mediated responses. Methods: Human saphenous vein segments were obtained from 35 patients undergoing coronary bypass surgery. Paired segments, one normal and the other deendothelized by gentle rubbing, were mounted for isometric recording of tension in organ baths. Concentration-response curves to vasopressin and desmopressin were determined in the presence and in the absence of either the V,-receptor antagonist d(CH 2 ) 5 Tyr(Me)AVP (10 −6 mol/L), the V 1 -V 2 receptor antagonist desGly-d(CH 2 ) 5 D-T…

AdultMaleAgonistReceptors Vasopressinmedicine.medical_specialtyVasopressinVasopressinsmedicine.drug_classVasodilator AgentsIndomethacinVasodilationHormone AntagonistsVasotocinIsometric ContractionInternal medicinemedicineHumansVasoconstrictor AgentsCyclooxygenase InhibitorsDeamino Arginine VasopressinSaphenous VeinEnzyme InhibitorsDesmopressinReceptorAgedDose-Response Relationship Drugbusiness.industryAntagonistMiddle AgedReceptor antagonistArginine VasopressinNG-Nitroarginine Methyl EsterEndocrinologyProstaglandinsFemaleSurgeryEndothelium VascularNitric Oxide Synthasemedicine.symptombusinessCardiology and Cardiovascular MedicineAntidiuretic Hormone Receptor AntagonistsVasoconstrictionhormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Vascular Surgery
researchProduct

Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsules.

2009

Purpose. The aim of the study was to analyze patients’ busulfan (BU) exposure after oral administration of extemporeanously prepared BU capsules prior to blood stem cell transplantation. Methods. Patients were treated with 1 mg/kg body weight BU administered orally every 6h on each of 4 consecutive days prior to blood stem cell transplantation. Each BU dose was administered in 1 gelatine capsule to be swallowed and containing the individually calculated dose of pure BU active substance. Blood samples were obtained from 6 adult patients 0, 30, 60, 90, 120, 180, 240, 300, and 360 min after the 1st, 5th, and 13th BU dose, frozen and analyzed subsequently by using a HPLC assay with UV detectio…

AdultMaleAlkylating AgentsTransplantation ConditioningDrug CompoundingAdministration OralCapsulesPharmacologyHplc assayPharmacokineticsOral administrationMedicineHumansPharmacology (medical)BusulfanCyclophosphamideChromatography High Pressure LiquidPeripheral Blood Stem Cell Transplantationmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryCapsuleMiddle AgedTransplantationOncologyTherapeutic drug monitoringConcomitantArea Under CurveDrug Therapy CombinationFemaleSpectrophotometry UltravioletDrug MonitoringbusinessBusulfanmedicine.drugJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
researchProduct

Application of headspace solid phase dynamic extraction gas chromatography/mass spectrometry (HS-SPDE-GC/MS) for biomonitoring of n-heptane and its m…

2011

Abstract Solid phase dynamic extraction (SPDE) is an innovative sample preparation and enrichment technique in connection with gas chromatography (GC). Using SPDE, we developed a method for simultaneous determination of n-heptane and its mono-oxygenated metabolites heptane-4-one, 3-one, 2-one, 4-ol, 3-ol, 2-ol, and 1-ol in blood. After adjustment of various extraction and desorption parameters, method validation resulted in limits of detection (LOD) between 0.006 (heptane-4-one) and 0.021 mg/L (heptane-1-ol). Intra-assay coefficients of variation ranged between 4.8% and 20.8% while relative recovery ranged between 100% and 117% (spiked concentration 0.128 mg/L, n  = 8). The method was appli…

AdultMaleAnalyteAnalytical chemistryToxicologySensitivity and SpecificityGas Chromatography-Mass SpectrometryHeptaneschemistry.chemical_compoundYoung AdultBiomonitoringHumansSample preparationDetection limitHeptaneInhalation ExposureChromatographyDose-Response Relationship DrugMolecular StructureChemistryExtraction (chemistry)Reproducibility of ResultsGeneral MedicineEnvironmental ExposureGas chromatographyGas chromatography–mass spectrometryBiomarkersEnvironmental MonitoringToxicology letters
researchProduct

Acute Myocardial Infarction and Proinflammatory Gene Variants

2007

We identified four genetic risk sets for acute myocardial infarction (AMI) from information on functional gene variants that favor inflammation or modulate cholesterol metabolism: IL6 -174 G/C, TNF -308 G/A, IL10 -1082 G/A, SERPINA3 -51 G/T, IFNG +874 T/A, HMGCR -911 C/A, and APOE ε2/3/4; 316 patients and 461 healthy subjects, all Italian. Putative risk alleles are shown underlined. The sets were identified using grade-of-membership analysis. Membership scores in the sets are automatically generated for individuals. The ''low intrinsic risk'' set had alleles that downregulate inflammation and cholesterol synthesis (IL6, TNF, ILl0, HMGCR). ''AMI across a broad age range'' carried multiple pr…

AdultMaleApolipoprotein EAdolescentMyocardial InfarctionGeneral Biochemistry Genetics and Molecular BiologyProinflammatory cytokinePathogenesischemistry.chemical_compoundApolipoproteins EHistory and Philosophy of SciencemedicineHumansGenetic Predisposition to DiseaseMyocardial infarctionAge of OnsetAlleleAllelesSerpinsAgedAged 80 and overbusiness.industryCholesterolGeneral NeuroscienceMiddle Agedmedicine.diseaseMiddle ageInterleukin 10CholesterolchemistryAMI Grade of Membership Genetic profile IL6 -174 G/C TNF -308 G/A IL10 -1082 G/A SERPINA3 -51 G/T IFNG +874 T/A HMGCR -911 C/A APOE ε2/3/4Acute DiseaseImmunologyCytokinesFemaleHydroxymethylglutaryl CoA Reductaseslipids (amino acids peptides and proteins)businessAnnals of the New York Academy of Sciences
researchProduct

Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability

2008

Previous in vitro studies using Caco-2 cell monolayers suggested a possible interaction between green and black tea and folic acid at the level of intestinal absorption. The main purpose of the present study was to investigate a possible pharmacokinetic interaction between tea and folic acid in healthy volunteers. In an open-labeled randomized cross-over study, the pharmacokinetic interaction between tea and folic acid (0.4 mg and 5 mg) was investigated in healthy volunteers. Water was used as the reference drink. Subjects ingested 0.4 mg folic acid tablets with water, green or black tea (0.3 g extract/250 ml) or 5 mg folic acid tablets with water or green tea (0.3 g extract/250 ml). Blood …

AdultMaleBiological AvailabilityPharmaceutical SciencePharmacologyIntestinal absorptionFood-Drug InteractionsFolic AcidPharmacokineticsIn vivoHumansPharmacology (medical)Black teaImmunoassayPharmacologyCross-Over StudiesDose-Response Relationship DrugTeaChemistryfood and beveragesGeneral MedicineMiddle AgedCrossover studyBioavailabilityDose–response relationshipFolic acidArea Under CurveLuminescent MeasurementsVitamin B ComplexFemaleBiopharmaceutics & Drug Disposition
researchProduct

Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain d…

2011

Abstract Context Cancer patients receiving high doses of opioids as background medication are challenging, and it would be useful clinically to know whether a rapid-onset opioid (ROO) for breakthrough cancer pain (BTcP) may be started at a dose proportional to the background opioid dose. Objectives The aim of this study was to assess the efficacy and safety of the fentanyl buccal tablet (FBT) in doses proportional to the opioid dose administered for background analgesia in a sample of patients with BTcP who were receiving high doses of opioids. Methods Twelve patients who were receiving opioids for background analgesia at doses equivalent to more than 500 mg of oral morphine and had adequat…

AdultMaleBreakthrough PainContext (language use)Settore MED/42 - Igiene Generale E ApplicataFentanylNeoplasmsHumansMedicineAdverse effectGeneral NursingAgedPain MeasurementDose-Response Relationship Drugbusiness.industryBreakthrough PainAdministration BuccalCancerclinical trialBuccal administrationMiddle Agedmedicine.diseaseFentanyl buccal tabletbreakthrough pain cancer patientAnalgesics OpioidFentanylTreatment OutcomeAnesthesiology and Pain MedicineOpioidAnesthesiaFemaleNeurology (clinical)businessCancer painmedicine.drug
researchProduct

Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study

2012

SummaryBackgroundStudies with inhaled corticosteroids (ICS) in smoking asthmatics have mostly shown poorer treatment responses than in non-smoking asthmatics.MethodsEuroSMART, an open, randomised, 6-month study, compared budesonide/formoterol (Symbicort ® Turbuhaler®)hhNeither the Symbicort SMART posology nor the dry powder formulation, Turbuhaler, is currently approved in the US. maintenance and reliever therapy (Symbicort SMART®) at two maintenance doses of budesonide/formoterol (160/4.5 μg), 1 × 2 and 2 × 2, in patients with asthma who were symptomatic despite treatment with ICS ± long-acting β2-agonists. The 8424 randomised patients included 886 smokers (11%; aged <40 years or with a sm…

AdultMaleBudesonidePulmonary and Respiratory MedicineSymbicort SMARTmedicine.medical_specialtyPeak Expiratory Flow RatePropensity-matched controlsDrug Administration Schedulelaw.inventionACQ-5Budesonide/formoterol maintenance and reliever therapyPharmacotherapyRandomized controlled triallawFormoterol FumarateSurveys and QuestionnairesInternal medicineAdministration InhalationmedicineHumansAnti-Asthmatic AgentsDosingBudesonideAsthmaSmokersDose-Response Relationship Drugbusiness.industrySmokingmedicine.diseaseAsthmaBronchodilator Agentsrespiratory tract diseasesTreatment OutcomeBudesonide/formoterolEthanolaminesAnesthesiaDisease ProgressionDrug Therapy CombinationFemaleFormoterol FumarateFormoterolbusinessmedicine.drugRespiratory Medicine
researchProduct

Men with elevated testosterone levels show more affiliative behaviors during contact with women

2012

Testosterone (T) is thought to play a key role in male–male competition and courtship in many vertebrates, but its precise effects are unclear. We explored whether courtship behaviour in humans is modulated and preceded by changes in T. Pairs of healthy male students first competed in a non-physical contest in which their T levels became elevated. Each participant then had a short, informal interaction with either an unfamiliar man or woman. The sex of the stimulus person did not affect the participants' behaviour overall. However, in interactions with women, those men who had experienced a greater T increase during the contest subsequently showed more interest in the woman, engaged in more…

AdultMaleCOURTSHIPAdolescentmedia_common.quotation_subjectEye contactNONVERBAL BEHAVIORaffiliative behaviourStimulus (physiology)male-male competitionCONTESTGeneral Biochemistry Genetics and Molecular BiologyDevelopmental psychologyCourtshipYoung Adult03 medical and health sciences0302 clinical medicineHORMONAL RESPONSESsexual selection0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyCHALLENGE HYPOTHESISYOUNG MENYoung adultSalivaSocial Behaviorhumans10. No inequalityResearch ArticlesGeneral Environmental Sciencemedia_commonGeneral Immunology and MicrobiologyCourtship displayMATING SYSTEMSCORTISOL05 social sciencesCOPULATORY-BEHAVIORMALE-RATSGeneral Medicine16. Peace & justiceSpainDOMINANCESexual selectiontestosteroneChallenge hypothesisFemaleGeneral Agricultural and Biological SciencesPsychology030217 neurology & neurosurgery
researchProduct